Compare · operating models
In-house vs outsourced PCN pharmacist.
Recruitment & retention
Getting (and keeping) the people.
- In-house: PCN advertises, interviews, onboards, manages turnover
- Outsourced: provider owns recruitment pipeline — typically faster mobilisation
- In-house: 12-week mobilisation typical; ARRS underspend risk if vacant
- Outsourced: 4–6 weeks typical; provider absorbs sickness/leave/maternity
- In-house: turnover is the PCN's problem
- Outsourced: turnover is the provider's problem — same-week cover
Supervision & QA
Who owns the clinical risk.
- In-house: PCN must find a designated clinical supervisor (often a GP)
- Outsourced: provider supplies senior pharmacist supervision weekly
- In-house: QA is usually informal unless deliberately built
- Outsourced: structured QA cycle sampling every pharmacist's work
- In-house: CPD and IP progression managed practice-by-practice
- Outsourced: provider-funded CPD, IP pipeline, RPS Faculty progression
Cost
What you actually pay.
- In-house: salary at ARRS reimbursable rate + on-costs
- Outsourced: managed-service fee covering salary, supervision, cover, QA, reporting, indemnity
- In-house: hidden cost of recruitment, vacancy, sickness, supervision time
- Outsourced: predictable monthly cost; provider absorbs cover risk
- In-house: ARRS allocation may be returned if underspent
- Outsourced: provider mobilises against ARRS underspend before year-end
Outcomes & evidence
Proving the value to the ICB.
- In-house: outcomes reporting is the PCN manager's responsibility — often the weakest link
- Outsourced: monthly outcomes dashboard built into the service
- In-house: ICB conversations require ad-hoc data pulls
- Outsourced: ICB-ready evidence pack every quarter
- In-house: ARRS audit preparation falls on the PCN
- Outsourced: supervision and audit evidence supplied by provider
Control & flexibility
Where in-house wins.
- In-house: pharmacist is fully integrated into practice culture from day one
- In-house: PCN can pivot the role week to week without contract renegotiation
- In-house: relationships with GP partners build over years
- In-house: practice-specific work (not DES) easier to direct
- Outsourced: harder to flex scope outside the agreed SLA
When in-house is the right answer.
If your PCN already has stable, well-supervised pharmacists, low turnover, an experienced PCN Manager who owns workforce and a senior pharmacist who's happy to lead supervision and QA — in-house works and is often cheaper. The risk is single-point-of-failure: one resignation, one maternity leave, and the model wobbles.
When outsourcing is the right answer.
If your PCN doesn't have spare supervision capacity, struggles with recruitment, has unspent ARRS to mobilise quickly, needs structured outcomes evidence for the ICB, or just wants the pharmacist function to not be the Clinical Director's problem any more — a managed service like BCS is built for that. You keep ARRS funding, you keep clinical oversight, you offload the staffing and governance burden.
Decide with us.
Book a discovery call
30 minutes — we'll walk through your specific PCN.
Choosing a PCN pharmacist provider
The full procurement checklist.
Outsourcing vs in-house — long-form
Original BCS analysis piece.
Talk to our Service Development team
30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.